LGALS1 and infection: Galectin-1, with its immunosuppressive profile and region-specific expression in the pediatric gastric mucosa, could serve as a biomarker for early-life infection persistence and for stratifying patients at risk for chronic infection with minimal inflammatory damage [89,110,111].